Spontaneous activity is an essential attribute of neuronal networks and plays a critical role in their development and maintenance. Upon blockade of activity with tetrodotoxin (TTX), neurons degenerate slowly and die in a manner resembling neurodegenerative diseases-induced neuronal cell death. The molecular cascade leading to this type of slow cell death is not entirely clear. Primary post-natal cortical neurons were exposed to TTX for up to two weeks, followed by molecular, biochemical and immunefluorescence analysis. The expression of the neuronal marker, neuron specific enolase (NSE), was down-regulated, as expected, but surprisingly, there was a concomitant and striking elevation in expression of tissue-type plasminogen activator (tPA). Immunofluorescence analysis indicated that tPA was highly elevated inside affected neurons. Transfection of an endogenous tPA inhibitor, plasminogen activator inhibitor-1 (PAI-1), protected the TTX-exposed neurons from dying. These results indicate that tPA is a pivotal player in slowly progressing activity deprivation-induced neurodegeneration.
Citation: Schonfeld-Dado E, Segal M (2011) Activity Deprivation Induces Neuronal Cell Death: Mediation by Tissue-Type Plasminogen Activator. PLoS ONE 6(10): e25919. https://doi.org/10.1371/journal.pone.0025919
Editor: Mark L. Baccei, University of Cincinnatti, United States of America
Received: June 6, 2011; Accepted: September 13, 2011; Published: October 6, 2011
Copyright: © 2011 Schonfeld-Dado, Segal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Israel Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Spontaneous ongoing network activity plays a critical role in neuronal development and survival, and regulates neuronal functionality in many neural systems –. It is manifested in the form of synchronized action potential discharges by neurons comprising a functional network, both in-vivo and in-vitro. Suppression of spontaneous ongoing network activity in culture using the voltage-gated sodium channel blocker TTX, can have fatal consequences to the exposed network which die following a prolonged period of activity deprivation –. This protracted cell death is caused by a gradual activation of cell death cascade and is accompanied by an increase in miniature excitatory post-synaptic currents (mEPSC) , proposed recently to be mediated by glial tumor necrosis factor (TNF) , another acknowledged regulator of cell death. Neuronal death is a key determinant in neurodegenerative diseases, and as yet there is little understanding of the molecular cascade leading to slow cell death, hence it is a major focus of attention in recent years.
Neuronal activity is responsible for the induction of key neuronal genes, known as activity-regulated genes (e.g. BDNF) . One of them is the serine protease tPA, the principle enzyme responsible for converting plasminogen into its active form, plasmin. tPA mediates extracellular matrix degradation (and is therefore the only approved drug for acute ischemic stroke)  and affects neuronal interactions, but is also implicated in neuronal death cascades –. The aim of the present study was to further explore the mechanistic aspects that govern activity deprivation-induced neuronal cell death. We found that tPA is up-regulated in the chronically silenced neurons at both the mRNA and the protein levels, and that it regulates TTX induced neurotoxicity. We therefore propose tPA as a crucial mediator of the toxic effects exerted by neuronal activity deprivation.
We have previously shown that chronic blockade of activity by exposure to TTX results in a slow and progressive degeneration of the silenced neurons , . This is expressed as a massive reduction in neuron number, and in a parallel reduction in the mRNA expression level of neuron specific enolase (NSE) (14D, Fig. 1A). We have also demonstrated the irreversibility of the death process, which starts after 4 days of exposure to TTX and proceeds even after TTX removal (designated the ‘wash’ period), through which NSE continues to decrease (Fig. 1A, n = 5 independent experiments, p = 2×10−9 - one way ANOVA, p = 0.97 - Shapiro-Wilk normality test). In order to gain additional mechanistic insights on cell death, we utilized real-time PCR analysis to examine the involvement of key genes in the process. One of the factors associated with the death process is tumor necrosis factor (TNF), which was indeed highly elevated during TTX treatment (8-fold, Fig. 1B), supporting previous suggestions . However, TNF did not remain elevated upon TTX removal, indicating that it may not be involved in the death process, which is triggered by but no longer dependent on continuous TTX presence. In sharp contrast, tPA, maintained its high expression level also when the cells were dying after removal of TTX (4-fold and 5-fold, respectively, Fig. 1C, n = 5 independent experiments, p<0.05 - one way ANOVA, p = 0.52 - Shapiro-Wilk normality test), indicating that it may be involved in neuronal death caused by activity deprivation (Fig. 1A). This elevation was detected in tPA protein levels as well, as demonstrated by immunefluorescence staining (Fig. 1D), correlating neuronal population loss with the induction of tPA expression in individual neurons, and its concentration inside the nucleus of the dying TTX-treated or -washed cell, in contrast to its somatic localization in control neurons.
(a–c) Real-time PCR analysis showing the change in the mean mRNA expression level of the neuronal marker NSE, TNF and tPA after short (4D) and long (14D) term TTX treatment and following 4 days of TTX treatment after which it was washed out and the cells were left to grow in regular medium for 10 more days (wash condition), relative to control (means±SEM; * = P<0.05; *** = P<0.001). (d) Immunoflorescence images of control, long term TTX-treated and TTX-washed cultures, stained for the neuronal marker NeuN (green - left panel, bar = 50 µm) or double-labeled for NeuN and for tPA (red - right panel, bar = 20 µm), showing the elevation in tPA protein levels among the treated neurons and its cellular localization.
To determine if indeed tPA operates through an intracellular route rather than the more prevalent extracellular arena, we tested for the presence of secreted toxic factors in both TTX-conditioned medium and in the medium conditioned by cells from which TTX was removed (‘wash conditioning’). Naïve cells were exposed to either fresh TTX, TTX-conditioned or wash-conditioned medium, and cell survival rates and tPA mRNA expression level were assessed (Fig. 2). While TTX-conditioned medium was as potent as medium containing fresh TTX in inducing neuronal cell death (Fig. 2A), wash-conditioned medium had no effect on cell viability unless TTX was added, in which case it induced death in 60% of the neurons (Fig. 2B, n = 3 independent experiments, p<0.03 - t-test, p = 0.83 - Shapiro-Wilk normality test). Under these conditions, tPA's mRNA level was elevated by roughly 6 fold in cells exposed to TTX-conditioned but not wash-conditioned medium (Fig. 2A, n = 3 independent experiments, p<0.04 - t-test, p = 0.83 - Shapiro-Wilk normality test).
(a) Mean cell survival rates of primary neuronal cultures following the application of 3 days TTX-conditioned medium or fresh TTX for 7 days. (b) Cell survival rates of primary neuronal cultures following the application of conditioned medium of cells that were treated for 4 days with TTX (‘wash conditioning’) and left for 3 more days in fresh medium, with or without the addition of fresh TTX, for 7 days (c) The change in tPA mRNA expression level in primary neuronal cultures following a week of incubation in TTX- or wash-conditioned medium (means±SEM; * P<0.05).
If indeed tPA has a critical role in the process of neuronal cell death, then interfering with its action should reduce it. Neurons were transfected with the endogenous inhibitor of tPA, PAI-1 (a gift of Rene Bernards, The Netherlands), which resulted in an elevation in cell survival rates compared to cells transfected with GFP or non-transfected cells (Fig. 3A&C).This protective effect, observed in other model systems as well , was due to the induced over-expression of PAI-1 as TTX by itself did not cause any elevation in endogenous PAI-1 protein levels (as might be assumed to be the case if any internal survival pathway was activated, Fig. 3B), and indeed the enrichment in PAI-1-expressing neurons was due to the transfection as appeared in the immunefluorescence analysis (Fig. 3A).
(a) Representative images of control and TTX-treated neuronal cultures stained for the neuronal marker NeuN (red), and for the tPA inhibitor PAI-1 (green), transfected with either GFP, PAI-1 or non-transfected controls (bar = 100 µm). (b) Control and TTX-treated neurons were stained for NeuN and for PAI-1. Cell survival rates of the NeuN-positive cells and of the PAI-1-positive cells out of the NeuN-positive population were estimated. (c) Cell survival rates of double-labeled cells of the three groups - Non-transfected, GFP and PAI-1, demonstrating the protection exerted by the over-expression of PAI-1.
The present results support a role for tPA in mediating activity deprivation-induced neuronal cell death. tPA's role in neuronal survival and death paradigms is quite diverse and controversial - there are many reports supporting its pro-survival effect on neurons both in-vivo and in-vitro –, but other studies have demonstrated its toxic effect or the protective effect of its endogenous inhibitor PAI-1 when secreted from astrocytes –. Our study reinforces the proposed involvement of tPA in neuronal death cascades, and also provides evidence for neuronal-originated PAI-1 (rather than glial) being beneficial in counteracting tPA toxic effects.
tPA mRNA expression levels were found to be elevated throughout TTX treatment in a gradual manner, corresponding to neuronal demise (Fig. 1A&C). This was not different from other genes tested, such as TNF which is an important mediator of neuronal apoptosis (Fig. 1B), but unlike these other genes, tPA remained highly elevated during the recovery period in which cells were dying independently of TTX presence. Assuming that neuronal death mechanisms are the same for both the chronic and the ‘wash’ phases, it is reasonable to assume that tPA has a major role in the death process in both conditions. The elevation in the mRNA level was accompanied by a corresponding elevation in the intracellular and intranuclear tPA protein levels in the treated neurons (chronically and washed, Fig. 1D) compared to control cells, suggesting that in our case, tPA may play an intracellular role in the death cascade. Another reinforcement for the suggestion that tPA may not mediate the death process in an extracellular manner is in the observation that secreted factors are playing no role in this cell death process as demonstrated in Fig. 2, showing that TTX-conditioned medium (containing TTX) was as potent as freshly-added TTX in eliciting cell death, and that the conditioned medium of cells in their recovery period is not toxic at all to naïve cells (Fig. 2A&B). Similar to the induction of tPA by chronic TTX treatment, there was a linear relation between tPA induction and the severity of the cell death exerted by the different types of conditioned media (Fig. 2C). If tPA is to play a crucial role in this death process, then blocking its activity would result in a protective effect on the dying neurons. To test this possibility we utilized the endogenous inhibitor of tPA in the cell, PAI-1, which is implicated by itself as a neuronal protecting agent. PAI-1 over-expression resulted in an increase in cell survival rates among TTX-treated neurons relative to cell transfected with a GFP or non transfected at all (Fig. 3). As before, the transfection experiments reinforce the assumption that tPA acts intracellularly, since application of the recombinant PAI-1 protein to the growing medium of the cells was shown not to be effective at all in elevating cell survival rates, unlike the case of the expression plasmid (unpublished data).
One of the reasons that neurodegenerative diseases are of a major concern is the fact that they are terminal and cureless as they are often diagnosed too late for medical intervention. For this reason preventive medicine which will engage in the early, pre-symptomatic stages of the disease should be developed - by detecting suspicious signs in specific neuronal populations (for example, elevation in tPA protein which occurs already after 4 days of treatment, Fig. 1C) we could try and treat them locally (for example by attenuating tPA activity, Fig. 3C) and prevent their demise and the collateral damage accompanied to it. We therefore believe that our study places tPA in a promising position as a future therapeutic target for neuroprotection.
Materials and Methods
Wistar rat pups were decapitated on postnatal day 3 (P3) and their brains removed and placed in a chilled (4°C), oxygenated Leibovitz L15 medium (Biological Industries, Beit Haemek, Israel) enriched with 0.6% glucose and Gentamicin (20 µg/ml; Sigma, St. Louis, MO). Bilateral cortical tissue was mechanically dissociated and plated on 12-mm glass coverslips at 4×105 cells per well in a 24-wells plate, or on 35 mm culture dishes at 1.5 to 2×106 cells. The plating medium consisted of 5% heat-inactivated horse serum (HS) and 5% fetal calf serum and was prepared in MEM (minimal essential medium)-Earl salts (Biological Industries, Beit Haemek, Israel) enriched with 0.6% glucose, Gentamicin, and 2 mM glutamax. Cells were left to grow in the incubator at 37°C, 5% CO2 for 4 days, at which time the medium was changed to 10% HS in enriched MEM, plus a mixture of 5′-fluoro-2-deoxyuridine/uridine (Sigma, 20 µg and 50 µg/ml, respectively). The medium is changed 4 days later to 10% HS in enriched MEM. TTX (at 1 µM, Alomone labs, Jerusalem, Israel) was added to the growth medium at 4 days in culture for up to 14 days of incubation period.
A lipofectamine 2000™ (Invitrogen, Carlsbad, CA, USA) mix was prepared at 1 µl/well with 50 µL/well optimem™ (Invitrogen, Carlsbad, CA, USA) and incubated for 5 min at room temperature. This was mixed with 1.5 µg/well total DNA in 50 µl/well optimem™ and incubated for 15 min at room temperature. The mix was then added to the cells and allowed to rest for 4–6 h until medium replacement. In most cases, at least several neurons were transfected. Co-transfection efficiency for several plasmids using this method was nearly 100%.
Cultures were washed briefly with standard extracellular solution (129 mM NaCl, 4 mM KCl, 10.5 mM glucose and 10 mM and HEPES, pH = 7.4), fixed in 4% paraformaldehyde with 4% sucrose for 20 min, and washed with phosphate-buffered saline (PBS). For fluorescence staining cells were blocked for 1 h in 10% GS with 0.1% triton X-100 and incubated overnight at 4°C with mouse αNeuN (chemicon, Massachusetts, USA; 1∶1000), rabbit αtPA (1∶400, Santa Cruz, California, USA) or rabbit αPAI-1 (1∶500, Santa Cruz, California, USA) followed by 1 h secondary antibody labeling (Alexa 488-labeled and Alexa 546-labeled goat anti-mouse - Molecular Probes, Eugene, OR; 1∶200). Cover slips were washed again, transferred onto glass slides and mounted for visualization with anti-fading mounting medium. Confocal image stacks were recorded using a Zeiss LSM 510 laser scanning microscope, a Zeiss 40× and 100× oil immersion objective. About 4 fields are taken per 12 mm coverslip for statistical analysis, at each case.
Quantitative reverse transcriptase (RT) Real Time-PCR analysis
Total cellular RNA was isolated using Qiagen RNeasy mini kit according to manufacture's instructions. Reverse transcription was performed with oligo dT primers and the RevertAid RT enzyme (Fementas) at 42°C for 60 min. The RT product from 500 ng of total RNA was applied to each 20-µL PCR reaction mixture containing 1× Absolute Blue Cyber Green PCR Mix (Thermo Scientific) and 250 nm of gene-specific forward and reverse primers. Each experimental set consisted of duplicate samples, non-template controls and serial dilutions of standard templates. PCR was performed in Rotor-Gene 6000 apparatus of Corbett with the following thermal cycle conditions: 15 min enzyme activation at 95°C and subsequent 40 three-step cycles of 95°C for 15 sec, 55°C for 30 sec and 72°C for 30 sec. As a reference, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and microtubule associated protein 2 (MAP2) cDNA levels were used. The rat specific primers used were the following:
- GAPDH - fw 5′ TCAACGGCACAGTCAAGGC 3′, rv 5′ CGCTCCTGGAAGATGGTGAT 3′;
- NSE - fw 5′ GCCGGCCTTTAATGTGATCAA 3′, rv 5′ CATGGCCAACTTGTTCCCAG 3′;
- TNF - fw 5′ GAGGTCAACCTGCCCAAGTACT 3′, rv 5′ CTGGGTAGAGAACGGATGAACAC 3′;
- tPA - fw 5′ TGCCCTAAGGGACCAACTGA 3′, rv 5′ TGGGTGCCACGGTAAGTCA 3′;
Emission data were analyzed by the Rotor Gene program and cycle threshold (CT) number was calculated automatically by it. We also verified that there was no detectable amplification in non-template controls. CT numbers showed a significant linear reverse correlation with logarithmic concentrations of standard templates. The original copy numbers of the first strand cDNA in RT samples were calculated from the CT numbers by fitting to the obtained standard correlation.
Every experiment was repeated at least 3 times, with several wells/35 mm dishes used for each treatment. The morphological data were summarized and analyzed automatically using Image-Pro Plus software. The stained neurons were counted in several fields of view in each glass. The statistical analysis of the data was done using t-tests or analysis of variance (ANOVA), after its normal distribution was verified using Shapiro-Wilk normality test. Significance was set at P<0.05.
Conceived and designed the experiments: ESD MS. Performed the experiments: ESD. Analyzed the data: ESD. Wrote the paper: ESD MS.
- 1. Tabuchi A (2007) Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function. Biol Pharm Bull 31(3): 327–35.A. Tabuchi2007Synaptic plasticity-regulated gene expression: a key event in the long-lasting changes of neuronal function.Biol Pharm Bull31332735
- 2. Corredor RG, Goldberg JL (2009) Electrical activity enhances neuronal survival and regeneration. J Neural Eng 6(5): 055001.RG CorredorJL Goldberg2009Electrical activity enhances neuronal survival and regeneration.J Neural Eng65055001
- 3. Loebrich S, Nedivi E (2009) The function of activity-regulated genes in the nervous system. Physiol Rev 89(4): 1079–103.S. LoebrichE. Nedivi2009The function of activity-regulated genes in the nervous system.Physiol Rev8941079103
- 4. Fishbein I, Segal M (2007) Miniature Synaptic Currents Become Neurotoxic to Chronically Silenced Neurons. Cerebral Cortex 17(6): 1292–306.I. FishbeinM. Segal2007Miniature Synaptic Currents Become Neurotoxic to Chronically Silenced Neurons.Cerebral Cortex1761292306
- 5. Schonfeld-Dado E, Fishbein I, Segal M (2009) Degeneration of cultured cortical neurons following prolonged inactivation: molecular mechanisms. J Neurochem 110(4): 1203–13.E. Schonfeld-DadoI. FishbeinM. Segal2009Degeneration of cultured cortical neurons following prolonged inactivation: molecular mechanisms.J Neurochem1104120313
- 6. Schonfeld-Dado E, Segal M (2009) Activity-dependent survival of neurons in culture: a model of slow neurodegeneration. J Neural Transm 116(11): 1363–9.E. Schonfeld-DadoM. Segal2009Activity-dependent survival of neurons in culture: a model of slow neurodegeneration.J Neural Transm1161113639
- 7. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087): 1054–9.D. StellwagenRC Malenka2006Synaptic scaling mediated by glial TNF-alpha.Nature440708710549
- 8. Flavell SW, Greenberg ME (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31: 563–90.SW FlavellME Greenberg2008Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system.Annu Rev Neurosci3156390
- 9. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, et al. (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282(21): 2019–26.WM ClarkS. WissmanGW AlbersJH JhamandasKP Madden1999Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.JAMA28221201926
- 10. Mataga N, Mizuguchi Y, Hensch TK (2004) Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron 44(6): 1031–41.N. MatagaY. MizuguchiTK Hensch2004Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator.Neuron446103141
- 11. Medina MG, Ledesma MD, Domínguez JE, Medina M, Zafra D, et al. (2005) Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 24(9): 1706–16.MG MedinaMD LedesmaJE DomínguezM. MedinaD. Zafra2005Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.EMBO J249170616
- 12. Takahashi H, Nagai N, Urano T (2005) Role of tissue plasminogen activator/plasmin cascade in delayed neuronal death after transient forebrain ischemia. Neurosci Lett 381(1–2): 189–93.H. TakahashiN. NagaiT. Urano2005Role of tissue plasminogen activator/plasmin cascade in delayed neuronal death after transient forebrain ischemia.Neurosci Lett3811–218993
- 13. Ho-Tin-Noé B, Enslen H, Doeuvre L, Corsi JM, Lijnen HR, et al. (2009) Role of plasminogen activation in neuronal organization and survival. Mol Cell Neurosci 42(4): 288–95.B. Ho-Tin-NoéH. EnslenL. DoeuvreJM CorsiHR Lijnen2009Role of plasminogen activation in neuronal organization and survival.Mol Cell Neurosci42428895
- 14. Soeda S, Koyanagi S, Kuramoto Y, Kimura M, Oda M, et al. (2008) Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost 100(6): 1014.S. SoedaS. KoyanagiY. KuramotoM. KimuraM. Oda2008Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system.Thromb Haemost10061014
- 15. Flavin MP, Zhao G (2001) Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury. J Neurosci Res 63(5): 388–94.MP FlavinG. Zhao2001Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.J Neurosci Res63538894
- 16. Echeverry R, Wu J, Haile WB, Guzman J, Yepes M (2010) Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest 120(6): 2194–205.R. EcheverryJ. WuWB HaileJ. GuzmanM. Yepes2010Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.J Clin Invest12062194205
- 17. Xin H, Li Y, Shen LH, Liu X, Wang X, et al. (2010) Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse. PLoS One 5(2): e9027.H. XinY. LiLH ShenX. LiuX. Wang2010Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.PLoS One52e9027
- 18. Buisson A, Nicole O, Docagne F, Sartelet H, Mackenzie ET, et al. (1998) Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J 12(15): 1683–91.A. BuissonO. NicoleF. DocagneH. SarteletET Mackenzie1998Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1.FASEB J1215168391
- 19. Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, et al. (2009) Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 110(4): 813–25.BP HeadHH PatelIR NiesmanJC DrummondDM Roth2009Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.Anesthesiology110481325
- 20. Flavin MP, Zhao G, Ho LT (2000) Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29(4): 347–54.MP FlavinG. ZhaoLT Ho2000Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro.Glia29434754
- 21. Gabriel C, Ali C, Lesné S, Fernández-Monreal M, Docagne F, et al. (2003) Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J 17(2): 277–9.C. GabrielC. AliS. LesnéM. Fernández-MonrealF. Docagne2003Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity.FASEB J1722779